# Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer

> **NCT07407244** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institute of Oncology Ljubljana** · enrollment: 268 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Neoadjuvant Chemotherapy

## Key facts

- **NCT ID:** NCT07407244
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-03-01
- **Primary completion:** 2017-03-31
- **Final completion:** 2026-02-28
- **Target enrollment:** 268 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07407244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07407244, "Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07407244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*